Kathmere Capital Management, LLC Bausch Health Companies Inc. Transaction History
Kathmere Capital Management, LLC
- $1.38 Billion
- Q4 2025
A detailed history of Kathmere Capital Management, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Kathmere Capital Management, LLC holds 12,790 shares of BHC stock, worth $80,321. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,790Holding current value
$80,321% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BHC
# of Institutions
264Shares Held
204MCall Options Held
2.54MPut Options Held
6.46M-
John Paulson Paulson & Co. Inc. | New York, Ny70.8MShares$444 Million16.32% of portfolio
-
Nomura Holdings Inc Tokyo, M015.7MShares$98.6 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$81.6 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$76.9 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A610.5MShares$66 Million0.01% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.27B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...